AC
Adam Crystal sold $661K of TNGX stock
Adam Crystal, President, R&D of Tango Therapeutics, Inc. (TNGX), sold 27,000 shares of TNGX stock worth $661K, per an SEC Form 4 filed Oct 5, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Oct 1, 2026, 4 days before it was made public.
TNGX has moved +4.3% since the trade date, from $24.45 to $25.50 (Nov 13, 2026 close).
- Traded
- Oct 1, 2026
- Disclosed
- Oct 5, 2026
- Filing delay
- 4 days
- Price since
- +4.3%
- Role
- President, R&D
- Source
- SEC Form 4